KRT18P9

Across TCGA pan-cancer cohorts, KRT18P9 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of KRT18P9’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where KRT18P9 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types KRT18P9 is over-expressed in tumor, although a few such as READ show the opposite, repressed pattern.

COAD, BRCA, and READ are the cancer types where KRT18P9 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in KRT18P9 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.075	.006	5	view →
BRCA	All	II,III,IV	+0.021	.005	4	view →
READ	Female	All	−0.038	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

KRT18P9–COAD

Open the COAD breakdown →